Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

about

Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events.

P2860

Q38643965-F6ACED35-1413-46A7-955C-956684FE40F7

P2860

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

Item

http://www.wikidata.org/entity/Q38856947

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

@en

type

Item

label

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

@en

prefLabel

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

@en

P1476

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis

@en

P2093

Reena Khanna

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

Infliximab for induction and maintenance therapy for ulcerative colitis

Elimination mechanisms of therapeutic monoclonal antibodies

Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the ACCENT I trial.

Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis.

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.

Subcutaneous bioavailability of golimumab at 3 different injection sites in healthy subjects.

Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study.

P304

1556-1563

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11095-017-2150-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Niels Vande Casteele

P577

2017-04-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28374338

http://www.w3.org/2001/XMLSchema#string

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

about

P2860

P2860

Therapeutic Drug Monitoring of Golimumab in the Treatment of Ulcerative Colitis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698